ANAB vs NWS
AnaptysBio Inc (ANAB) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
NWS (NWS) common stock.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
NWS does not have a complete income-statement cache yet.
ANAB currently screens at market cap $1.62B. NWS currently screens at market cap $0.
Not investment advice. Open the ANAB and NWS stock pages for the full models.
Not investment advice.